Gervacio, Baby Girl .
HRN: 27-27-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/25/2025
07/01/2025
IV
44mg
OD
T/C MAS
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes